GSK secures another ex-China ADC deal with Hansoh Pharma with $185M upfront
The year of antibody-drug conjugates isn’t done yet, as GSK is adding another licensing partnership with Hansoh Pharma for another ADC with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
